Abiopharma

Leonardo DRS Announces Financial Results for First Quarter 2026

Fortive To Present at 2026 Wolfe Research 19th Annual Global Transportation & Industrials Conference

Telesat reports results for the quarter ended March 31, 2026

Nuvectis Pharma, Inc. Reports First Quarter 2026 Financial Results and Business Highlights

ImmunityBio to Present New Comparative Data, Scientific Advances in Non-Muscle Invasive Bladder Cancer CIS and an Update on BCG Naïve Registrational Trial at American Urological Association Annual Meeting

Cytokinetics Announces Positive Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy

Surgery Partners, Inc. Announces First Quarter 2026 Results Reaffirms Full Year 2026 Guidance

Cambridge Financial Group, Inc. and First Seacoast Bancorp, Inc. Agree to Merge

Ballard Reports Q1 2026 Results USA - English USA - English

Kura Oncology to Report First Quarter 2026 Financial Results